Growing community of inventors

Abingdon, United Kingdom

Chris Yarnold

Average Co-Inventor Count = 8.27

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Chris YarnoldTakashi Kondo (6 patents)Chris YarnoldAkira Imagawa (6 patents)Chris YarnoldSteve Courtney (6 patents)Chris YarnoldOsamu Ichihara (6 patents)Chris YarnoldStuart Flanagan (6 patents)Chris YarnoldTaihei Nishiyama (4 patents)Chris YarnoldRyo Suzuki (2 patents)Chris YarnoldGareth Neil Brace (2 patents)Chris YarnoldShingo Nakatani (2 patents)Chris YarnoldSho Kouyama (2 patents)Chris YarnoldElise Gadouleau (2 patents)Chris YarnoldJohn Barker (2 patents)Chris YarnoldAnthony Richardson (2 patents)Chris YarnoldChris Yarnold (6 patents)Takashi KondoTakashi Kondo (54 patents)Akira ImagawaAkira Imagawa (6 patents)Steve CourtneySteve Courtney (6 patents)Osamu IchiharaOsamu Ichihara (6 patents)Stuart FlanaganStuart Flanagan (6 patents)Taihei NishiyamaTaihei Nishiyama (10 patents)Ryo SuzukiRyo Suzuki (33 patents)Gareth Neil BraceGareth Neil Brace (9 patents)Shingo NakataniShingo Nakatani (9 patents)Sho KouyamaSho Kouyama (7 patents)Elise GadouleauElise Gadouleau (5 patents)John BarkerJohn Barker (2 patents)Anthony RichardsonAnthony Richardson (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ono Pharmaceutical Co., Ltd. (6 from 575 patents)


6 patents:

1. 10882855 - Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases

2. 10717738 - Pyrimidinone and its derivatives inhibiting factor XIa

3. 10336741 - Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases

4. 9732085 - Pyridinone and pyrimidinone derivatives as factor Xia

5. 9585881 - Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases

6. 9394250 - Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/22/2026
Loading…